Bartosz Chmielowski

26PUBLICATIONS
252CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Apr 21, 2026
Cellular neighborhoods govern antitumor T-cell infiltration following anti-CTLA-4 in melanoma with primary resistance to anti-PD-1.

|Mar 05, 2026
Neoadjuvant BO-112 and Hypofractionated Radiation Therapy with or without Nivolumab in Soft-Tissue Sarcoma: Preclinical and Phase I Results.

Jie Deng, Aastha Pal, Stefano Testa

|Jan 29, 2026
Neoadjuvant PD-1 blockade in surgically resectable desmoplastic melanoma: cohort A of the phase 2 SWOG S1512 trial.

Kari L Kendra, Shay L Bellasea, Zeynep Eroglu

|Jan 10, 2026
Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus.

Juan Alban, R Christopher Bowen, David A Reichstein

|Jul 08, 2025
RP1 Combined With Nivolumab in Advanced Anti-PD-1-Failed Melanoma (IGNYTE).

Michael K Wong, Mohammed M Milhem, Joseph J Sacco

|Jul 02, 2025
Human cancer-targeted immunity via transgenic hematopoietic stem cell progeny.

Theodore S Nowicki, Nataly Naser Al Deen, Cole W Peters

Pageof 5

Frequent Collaborators

8 joint publications

Antoni Ribas

7 joint publications

Fritz Christian Eilber

6 joint publications

Katie M Campbell

5 joint publications

Tara A Russell